Aptamer-based targeted delivery of functional nucleic acids

S **e, W Sun, T Fu, X Liu, P Chen, L Qiu… - Journal of the …, 2023 - ACS Publications
Functional nucleic acid (NA)-based drugs have a broad range of applications since they
allow the alteration and control of gene/protein expression patterns in cells. In principle …

Advances in aptamer-mediated targeted delivery system for cancer treatment

S He, Y Du, H Tao, H Duan - International Journal of Biological …, 2023 - Elsevier
Aptamers with high affinity and specificity for certain targets have rapidly become a novel
class of targeted ligands applicated in drug delivery. Based on the excellent characteristics …

[HTML][HTML] Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications

LP Jahromi, M Rothammer, G Fuhrmann - Advanced Drug Delivery …, 2023 - Elsevier
Lipid-based nanocarriers have been extensively investigated for their application in drug
delivery. Particularly, liposomes are now clinically established for treating various diseases …

Nanoparticles: attractive tools to treat colorectal cancer

NK Younis, R Roumieh, EP Bassil… - Seminars in Cancer …, 2022 - Elsevier
Colorectal Cancer (CRC) is one of the leading causes of cancer-related deaths worldwide.
Despite the notable advances achieved over the last few decades, CRC remains a hard-to …

[HTML][HTML] Unraveling the Multifaceted Roles of Extracellular Vesicles: Insights into Biology, Pharmacology, and Pharmaceutical Applications for Drug Delivery

A Al-Jipouri, À Eritja, M Bozic - International Journal of Molecular …, 2023 - mdpi.com
Extracellular vesicles (EVs) are nanoparticles released from various cell types that have
emerged as powerful new therapeutic option for a variety of diseases. EVs are involved in …

Aptamer-Based Smart Targeting and Spatial Trigger–Response Drug-Delivery Systems for Anticancer Therapy

D Park, SJ Lee, JW Park - Biomedicines, 2024 - mdpi.com
In recent years, the field of drug delivery has witnessed remarkable progress, driven by the
quest for more effective and precise therapeutic interventions. Among the myriad strategies …

[HTML][HTML] Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance

R Xue, Y Pan, L **a, J Li - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Multidrug resistance (MDR) of tumors is one of the main reasons for the failure of
chemotherapy. Multidrug resistance refers to the cross-resistance of tumor cells to multiple …

Nanoparticles containing oxaliplatin and the treatment of colorectal cancer

H Mahaki, M Mansourian, Z Meshkat… - Current …, 2023 - ingentaconnect.com
Background: Colorectal cancer (CRC) is a highly widespread malignancy and ranks as the
second most common cause of cancer-related mortality. Objective: Cancer patients …

Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review

IS Ibrahim, MS Chellathurai, S Mahmood… - International Journal of …, 2024 - Elsevier
Colorectal cancer (CRC) continues to be one of the most prevalent and deadliest forms of
cancer worldwide, despite notable advancements in its management. The prognosis for …

Nanoliposomal oxaliplatin ameliorates chemotherapy-induced neuropathy

M Alaei, M Moetamani-Ahmadi, H Mahaki, H Fiuji… - Neuroscience …, 2023 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN) is an important adverse effect of
treatment with oxaliplatin (OXA). We have developed PEGylated nanoliposomal oxaliplatin …